Clinical Trial Update: The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 0.01% atropine eye drops to slow axial elongation and refractive progression in children with myopia, compared with a control …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• 0.01% atropine eye drops (atropine)

Snippet

Sponsor: Liaquat National Hospital & Medical College | Conditions: Focus on Axial Length | Phase 2 | Status: RECRUITING